- Home
- OKTA vs BNTX Comparison
OKTA vs BNTX Comparison
Compare OKTA & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | OKTA | BNTX |
|---|---|---|
| Founded | 2009 | 2008 |
| Country | United States | Germany |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 23.8B | 24.2B |
| IPO Year | 2017 | 2019 |
Fundamental Metrics
Financial Performance| Metric | OKTA | BNTX |
|---|---|---|
| Price | $170.60 | $103.76 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 36 | 13 |
| Target Price | $103.60 | ★ $133.46 |
| AVG Volume (30 Days) | ★ 3.5M | 1.5M |
| Earning Date | 05-26-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 2083.33 | N/A |
| EPS | ★ 1.07 | N/A |
| Revenue | ★ $2,919,000,000.00 | N/A |
| Revenue This Year | $11.27 | N/A |
| Revenue Next Year | $9.36 | $3.37 |
| P/E Ratio | $158.24 | ★ N/A |
| Revenue Growth | ★ 11.84 | N/A |
| 52 Week Low | $62.66 | $79.81 |
| 52 Week High | $174.85 | $124.00 |
Technical Indicators
Market Signals| Indicator | OKTA | BNTX |
|---|---|---|
| Relative Strength Index (RSI) | 62.03 | 52.93 |
| Support Level | $130.33 | $87.58 |
| Resistance Level | $174.85 | $104.05 |
| Average True Range (ATR) | 8.14 | 4.11 |
| MACD | 2.53 | -0.76 |
| Stochastic Oscillator | 88.30 | 41.22 |
Price Performance
Historical ComparisonAbout OKTA Okta Inc.
Okta is a cloud-native security company specializing in identity and access management. The San Francisco-based firm went public in 2017 and serves two key client stakeholder groups: workforces and customers. Okta's workforce offerings enable a company's employees, contractors, and partners to securely access its cloud-based and on-premises resources. The firm's customer offering, delivered via its Auth0 platform, allow clients to provide secure access experiences to their own end users.
About BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens and neoantigens; monospecific and bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.